{"id":"https://openalex.org/W1908894798","doi":null,"title":"Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity.","display_name":"Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity.","publication_year":1996,"publication_date":"1996-04-01","ids":{"openalex":"https://openalex.org/W1908894798","mag":"1908894798","pmid":"https://pubmed.ncbi.nlm.nih.gov/9816217"},"language":"en","primary_location":{"id":"pmid:9816217","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9816217","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110137545","display_name":"Neal J. Meropol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N J Meropol","raw_affiliation_strings":["Divisions of Medicine, Molecular Medicine, Molecular Immunology, and Biostatistics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Medicine, Molecular Medicine, Molecular Immunology, and Biostatistics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M Porter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Porter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053789040","display_name":"Leslie E. Blumenson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L E Blumenson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113706938","display_name":"M J Lindemann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J Lindemann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038111347","display_name":"Raymond P. Perez","orcid":"https://orcid.org/0000-0002-7432-2411","observed_orcids":["https://orcid.org/0000-0002-7432-2411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R P Perez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"L Vaickus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Vaickus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004776795","display_name":"Gregory Loewen","orcid":"https://orcid.org/0000-0002-7185-0796","observed_orcids":["https://orcid.org/0000-0002-7185-0796"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G M Loewen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111674028","display_name":"Patrick J. Creaven","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P J Creaven","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059999849","display_name":"K A Wilkes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K A Wilkes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013275738","display_name":"Martin A Giedlin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M A Giedlin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5049192022","display_name":"Michael A. Caligiuri","orcid":"https://orcid.org/0000-0002-4095-3020","observed_orcids":["https://orcid.org/0000-0002-4095-3020"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M A Caligiuri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6534,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.83533899,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"2","issue":"4","first_page":"669","last_page":"77"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9559999704360962},{"id":"https://openalex.org/keywords/low-dose-il-2","display_name":"low-dose interleukin-2","score":0.9110000133514404},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8289999961853027},{"id":"https://openalex.org/keywords/nk-cell-expansion","display_name":"NK cell expansion","score":0.9409999847412109},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":0.7749999761581421},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7879999876022339},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.4860000014305115},{"id":"https://openalex.org/keywords/anti-il-2-antibody","display_name":"anti-IL-2 antibody","score":0.9150000214576721},{"id":"https://openalex.org/keywords/il-2-receptor","display_name":"interleukin-2 receptor","score":0.8579999804496765},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.6380000114440918},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.43700000643730164}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.7042588591575623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6205620765686035},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5585586428642273},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.5302110910415649},{"id":"https://openalex.org/C2776312127","wikidata":"https://www.wikidata.org/wiki/Q5299247","display_name":"Dose-ranging study","level":5,"score":0.5171589255332947},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.4555678069591522},{"id":"https://openalex.org/C2908885563","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Aldesleukin","level":4,"score":0.4431026577949524},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4368338882923126},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.42832285165786743},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.4250539541244507},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3789437711238861},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3491050601005554},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34687894582748413},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.32182562351226807},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2318369746208191},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21492257714271545},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.20281130075454712},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.179570734500885},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.15138861536979675},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9816217","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9816217","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"mag:1908894798","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9816217","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G5002143310","display_name":"THERAPY FOR AIDS CENTRAL NERVOUS SYSTEM LYMPHOMA","funder_award_id":"R01CA065670","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W18011009","https://openalex.org/W1644497916","https://openalex.org/W1861839200","https://openalex.org/W1866302376","https://openalex.org/W1914396593","https://openalex.org/W1972953885","https://openalex.org/W1975568557","https://openalex.org/W2033440285","https://openalex.org/W2086116992","https://openalex.org/W2095135744","https://openalex.org/W2095636772","https://openalex.org/W2132363654","https://openalex.org/W2136445642","https://openalex.org/W2143381422","https://openalex.org/W2179970611","https://openalex.org/W2309081305","https://openalex.org/W2314331148","https://openalex.org/W2395314415","https://openalex.org/W2412763372","https://openalex.org/W2417706018","https://openalex.org/W2430254743","https://openalex.org/W3166315590"],"related_works":["https://openalex.org/W1998870570","https://openalex.org/W1861839200","https://openalex.org/W2095636772","https://openalex.org/W2159647567","https://openalex.org/W7098919520","https://openalex.org/W260508585","https://openalex.org/W2056122685","https://openalex.org/W2033440285","https://openalex.org/W2045863333","https://openalex.org/W1997341644"],"abstract_inverted_index":{"We":[0],"aimed":[1],"to":[2,37,83,164,217],"determine":[3],"the":[4,48,64,112,195],"toxicity":[5,105],"and":[6,63,100,119,177],"immunological":[7],"effects":[8,123],"of":[9,26,35,66,182,190,197,245,257],"daily":[10,23,254],"s.c.":[11,24,255],"administered":[12],"low-dose":[13,258],"interleukin":[14],"(IL)":[15],"2.":[16],"Adult":[17],"cancer":[18],"patients":[19,39,72,234],"received":[20],"a":[21,162],"single":[22],"injection":[25],"IL-2":[27,44,60,77,138,191,204,227,259],"as":[28],"outpatients":[29],"for":[30],"90":[31],"consecutive":[32],"days.":[33],"Cohorts":[34],"four":[36],"nine":[38],"were":[40,69,73,124,129,172],"treated":[41,74],"at":[42,75,109,148,174,225],"escalating":[43],"dose":[45,51,78,102,150,155],"levels":[46,79,171,228],"until":[47],"maximum":[49],"tolerated":[50],"(MTD)":[52],"was":[53,92,154],"defined.":[54],"Peripheral":[55],"blood":[56],"mononuclear":[57],"cell":[58,144],"phenotyping,":[59],"serum":[61],"levels,":[62],"presence":[65],"anti-IL-2":[67,237],"antibodies":[68],"investigated.":[70],"Thirty-eight":[71],"seven":[76],"ranging":[80,160,214],"from":[81,161,215],"0.4":[82],"1.75":[84],"million":[85],"International":[86],"Units":[87],"(mIU)/m2":[88],"daily.":[89],"The":[90],"MTD":[91],"1.25":[93],"mIU/m2,":[94],"with":[95,212,253,260],"constitutional":[96,121],"side":[97,122],"effects,":[98],"vomiting,":[99],"hyperglycemia":[101],"limiting.":[103],"Severe":[104],"did":[106],"not":[107,130],"occur":[108],"or":[110],"below":[111],"MTD,":[113],"although":[114],"mild":[115,120],"local":[116],"skin":[117],"reaction":[118],"common.":[125],"Objective":[126],"tumor":[127],"regressions":[128],"observed":[131],"during":[132],"this":[133],"Phase":[134],"I":[135],"trial.":[136],"Low-dose":[137],"resulted":[139],"in":[140,187,251],"natural":[141],"killer":[142],"(NK)":[143],"(CD3(-)":[145],"CD56(+))":[146],"expansion":[147,223,244],"all":[149],"levels.":[151],"This":[152],"effect":[153],"dependent":[156],"(P":[157,219],"<":[158],"0.01),":[159],"154":[163],"530%":[165],"increase":[166],"over":[167],"baseline.":[168],"Peak":[169],"NK":[170,198,222,246],"achieved":[173,250],"6-8":[175],"weeks":[176,181],"sustained":[178],"through":[179],"12":[180],"therapy.":[183],"As":[184],"predicted":[185],"by":[186],"vitro":[188],"studies":[189],"receptor":[192],"structure-activity":[193],"relationships,":[194],"subset":[196],"cells":[199,247],"that":[200,242],"constitutively":[201],"express":[202],"high-affinity":[203],"receptors":[205],"(CD3(-)CD56(bright+))":[206],"showed":[207],"more":[208],"profound":[209],"dose-dependent":[210],"expansion,":[211],"increases":[213],"368":[216],"2763%":[218],"=":[220],"0.015).":[221],"occurred":[224],"peak":[226],"<10":[229],"pM":[230],"(2.3":[231],"IU/ml).":[232],"Three":[233],"developed":[235],"nonneutralizing":[236],"antibodies.":[238],"Thus,":[239],"we":[240],"concluded":[241],"selective":[243],"may":[248],"be":[249],"vivo":[252],"injections":[256],"minimal":[261],"toxicity.":[262]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}